Moderna Inc traded at $149.95 this Friday July 1st, increasing $7.10 or 4.97 percent since the previous trading session. Looking back, over the last four weeks, Moderna Inc gained 6.97 percent. Over the last 12 months, its price fell by 36.00 percent. Looking ahead, we forecast Moderna Inc to be priced at 145.89 by the end of this quarter and at 134.34 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 14.37 0.28 1.99% -40.86%
Acorda Therapeutics 0.48 0.01 3.20% -89.34%
Agios Pharmaceuticals 23.36 1.19 5.37% -58.08%
Alnylam Pharmaceuticals 148.25 2.40 1.65% -13.52%
Amgen 245.55 2.25 0.92% -1.27%
Arrowhead Research 35.96 0.75 2.13% -43.04%
Biogen 210.63 6.69 3.28% -39.60%
Bluebird Bio 4.28 0.14 3.38% -86.36%
BioMarin Pharmaceutical 84.98 2.11 2.55% -0.57%
Esperion Therapeutics 6.45 0.09 1.42% -68.52%
Gilead Sciences 62.36 0.55 0.89% -10.01%
GlaxoSmithKline 1,802.60 17.00 0.95% 25.84%
Intercept Pharmaceuticals 14.13 0.32 2.32% -29.31%
Incyte Corp 77.67 1.70 2.24% -7.07%
Ionis Pharmaceuticals 38.06 1.04 2.81% -4.66%
Mirati Therapeutics 71.18 4.05 6.03% -57.53%
Puma Biotechnology 2.78 -0.07 -2.46% -68.48%
Ultragenyx Pharmaceutical 62.65 2.99 5.01% -33.50%
Regeneron Pharmaceuticals 595.40 4.27 0.72% 2.01%
Seattle Genetics 180.11 3.17 1.79% 14.52%
Sangamo BioSciences 4.28 0.14 3.38% -63.45%
Sarepta Therapeutics 75.71 0.75 1.00% 0.62%
United Therapeutics 238.00 2.36 1.00% 29.12%
Vertex Pharmaceuticals 287.32 5.53 1.96% 43.27%

Indexes Price Day Year
USNDX 11702 -28.10 -0.24% -20.86%

Moderna Inc
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.